Lifeboat Foundation

Accelerating Breakthroughs in Critical and Emerging Technologies — Dr. Erwin Gianchandani, Ph.D. — Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation (NSF)

Dr. Erwin Gianchandani, Ph.D. is Assistant Director for Technology, Innovation and Partnerships, U.S. National Science Foundation, leading the newly established TIP Directorate (https://new.nsf.gov/tip/leadership).

Continue reading “Dr Erwin Gianchandani — Assistant Director for Technology, Innovation and Partnerships, U.S. NSF” »

Engineering organs to replace damaged hearts or kidneys in the human body may seem like something out of a sci-fi movie, but the building blocks for this technology are already in place. In the burgeoning field of tissue engineering, live cells grow in artificial scaffolds to form biological tissue. But to evaluate how successfully the cells develop into tissue, researchers need a reliable method to monitor the cells as they move and multiply.

Now, scientists at the National Institute of Standards and Technology (NIST), the U.S Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have developed a noninvasive method to count the live cells in a three-dimensional (3D) scaffold. The real-time technique images millimeter-scale regions to assess the viability of the cells and how the cells are distributed within the scaffold—an important capability for researchers who manufacture complex biological tissues from simple materials such as living cells.

Their findings have been published in the Journal of Biomedical Materials Research Part A.

An artificial intelligence system enables robots to conduct autonomous scientific experiments—as many as 10,000 per day—potentially driving a drastic leap forward in the pace of discovery in areas from medicine to agriculture to environmental science.

Reported today in Nature Microbiology, the research was led by a professor now at the University of Michigan.

Continue reading “AI could run a million microbial experiments per year, says study” »

Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the positive effects of psilocybin on color blindness.

Published in the journal Drug Science, Policy and Law, the researchers highlight some implications surrounding a single reported vision improvement self-study by a colleague and cite other previous reports, illustrating a need to understand better how these psychedelics could be used in therapeutic settings.

Past reports have indicated that people with color vision deficiency (CVD), usually referred to as color blindness, experience better color vision after using lysergic acid diethylamide (LSD) or psilocybin (magic mushrooms). There is a lack of scientific evidence for these claims, as researching the effects of these drugs has been highly restricted.

Year 2015 😗😁

Indigo-Clean is a new light that is capable of killing bacteria. Used in a healthcare settings, the device could help prevent the spread of dangerous microorganisms, including Methicillin-resistant Staphylococcus aureus (MRSA), a bacterium responsible for several difficult-to-treat infections in humans.

Bacteria in the air absorb the indigo-colored light, which then creates a chemical reaction within the microorganism. This creates an environment that acts like bleach, killing the microscopic lifeform, reports Tech Times.

Continue reading “New Indigo Light Kills Bacteria at Hospitals” »

Long-term sufferers of chronic back pain experienced dramatic reductions in pain and related disability that remained at their one-year follow-up after taking part in a new treatment tested by Curtin-Macquarie-Monash University research.

Published today in the journal The Lancet, the research found large clinically significant improvements in the intensity of pain and pain-related disability among almost 500 people who had been seeking help for their pain for an average of four years before trialing the new treatment.

The treatment, which delivered a health care and work productivity saving of more than $5,000 per person, took a whole-person approach by also helping people to make lifestyle changes aimed at improving their social and emotional health.

Amidst concerns that employees could be entering sensitive information into the ChatGPT artificial intelligence model, a data privacy vendor has launched a redaction tool aimed at reducing companies’ risk from inadvertently exposing customer and employee data.

Private AI’s new PrivateGPT platform integrates with OpenAI’s high-profile chatbot, automatically redacting 50+ types of personally identifiable information (PII) in real time as users enter ChatGPT prompts.

PrivateGPT sits in the middle of the chat process, stripping out everything from health data and credit-card information to contact data, dates of birth, and Social Security numbers from user prompts, before sending them through to ChatGPT. When ChatGPT responds, PrivateGPT re-populates the PII within the answer, to make the experience more seamless for users, according to a statement this week from PrivateGPT creator Private AI.

A team of scientists at the Instituto Italiano di Tecnologia in Italy has created the world’s first completely edible and rechargeable battery. The innovative battery could be used to power edible electronics for health diagnostics, food quality monitoring, and edible soft robotics.

Edible Rechargeable Battery

Continue reading “Scientists Create the World’s First Edible Rechargeable Battery” »

Patients with kidney failure have a high mortality rate. There is an exponential increase in the number of patients experiencing kidney failure requiring treatment with life-saving kidney replacement therapy (KRT), including hemodialysis (HD), peritoneal dialysis (PD) or kidney transplantation.

Researchers have found inj a new study that Intradialytic exercise may improve survival rates in adult patients receiving hemodialysis.

The new study has been published in the BMC Nephrology.